Study: New blood thinner works as well as Coumadin

Nov 15, 2010 By MARILYNN MARCHIONE , AP Medical Writer

(AP) -- A study finds that a new and easier-to-use blood thinner prevents strokes in people with a common heart rhythm problem as well as Coumadin does, and without an increase in bleeding or side effects.

The drug is called rivaroxaban (riv-ah-ROCKS-ah-ban). It was tested against warfarin, the generic version of Coumadin, in more than 14,000 people with atrial . That's the most common heart rhythm problem in America. It occurs when the upper parts of the heart quiver instead of beating normally. This raises the risk of clots that can cause a .

Johnson & Johnson and Bayer Healthcare plan to seek federal approval to sell the drug later this year. Doctors gave results of the study Monday at a heart conference in Chicago.

Explore further: Police seize millions in huge fake Viagra swoop

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Study: Plavix plus aspirin helps prevent strokes

Mar 31, 2009

(AP) -- Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday.

Blood-Thinning Drug Linked to Increased Bleeding in Brain

Sep 29, 2008

(PhysOrg.com) -- Patients who take the commonly used blood-thinning drug warfarin face larger amounts of bleeding in the brain and increased risk of mortality if they suffer a hemorrhagic stroke, new research from the University ...

Blood thinner causes stroke in some dialysis patients

Aug 27, 2009

The blood thinner warfarin can prevent strokes in most individuals with abnormal heart rhythms, but the drug may have the opposite effect in kidney disease patients on dialysis, according to a study appearing in an upcoming ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

1 hour ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments : 0